Intellipharmaceutics international inc. (IPCI)
Income statement / TTM
Aug'18May'18Nov'17Aug'17May'17Feb'17May'16Feb'16Feb'14Feb'13
Revenues
Licensing (Note 3)

0

0

-

0

0

-

-

-

-

-

Licensing (Note 3)

-

-

-

-

-

-

-

-

0

-

Milestone (Note 3)

-

-

-

-

-

-

-

-

0

-

Up-front fees (Note 3)

0

0

-

0

0

-

-

-

-

-

Revenues

0

0

-

0

0

-

-

-

0

-

Cost of good sold
Cost of goods sold

0

0

-

0

0

-

-

-

-

-

Gross Margin

0

0

-

0

0

-

-

-

-

-

Expenses
Research and development

0

0

-

0

0

-

-

-

0

0

Selling, general and administrative

0

0

-

0

0

-

-

-

0

0

Depreciation

0

0

-

0

0

-

-

-

-

-

Depreciation

-

-

-

-

-

-

-

-

0

0

Expenses

0

0

-

0

0

-

-

-

0

0

Loss from operations

0

0

-

0

0

-

-

-

-

-

Loss from operations

-

-

-

-

-

-

-

-

0

0

Fair value adjustment of derivative liabilities

-

-

-

-

-

-

-

-

-

0

Net foreign exchange gain (loss)

0

0

-

0

0

-

-

-

0

0

Interest income

0

0

-

0

0

-

-

-

0

0

Interest expense

0

0

-

0

0

-

-

-

0

0

Net loss and comprehensive loss

0

0

-

0

0

-

-

-

0

0

Foreign exchange translation adjustment

-

-

-

-

-

-

-

-

-

0

Comprehensive loss

-

-

-

-

-

-

-

-

0

0

Loss per common share, basic and diluted

-0.91

-0.07

0.67

-0.83

-0.06

-0.07

-0.08

-0.09

-

-

Weighted average number of common shares outstanding, basic and diluted

4,353

41,838

60,631

3,071

30,388

29,966

24,752

24,431

-

-

Basic (in Dollars per share)

-

-

-

-

-

-

-

-

0.10

-0.07

Diluted (in Dollars per share)

-

-

-

-

-

-

-

-

0.09

-0.07

Basic (in Shares)

-

-

-

-

-

-

-

-

22,280

17,906

Diluted (in Shares)

-

-

-

-

-

-

-

-

23,561

17,906